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background:  The study aimed to investigate the association between time delay (TD) from symptom onset-to-reperfusion and efficacy of P2Y12 
inhibitors in patients with STEMI and pPCI.
methods: PCI registry data were analyzed. Inhibition of P2Y12 signaling was tested by VASP index 20±4 h after Clopidogrel (600mg)/Prasugrel 
(60mg)/Ticarelor (180mg). High on-treatment platelet reactivity (HTPR) was defined as VASP index ≥50%.
results: Study group consisted of 152 patients (63.0±14.0ys.,66% men). The mean(SD) duration of TD was 307(371)min. The HTPR was 
significantly more frequent in patients after 600mg clopidogrel with TD< 6hs.
Conclusion: Our results support a reloading with prasugrel/ticagrelor in STEMI patients treated with pPCI who were initially loaded with 
clopidogrel, especially in the early phase.
 
Time delay and efficacy of P2Y12 inhibitors
Time delay in Clopidogrel group (N=130) VASP≥ 50% P-value (1)
VASP %
Mean ± SD
P-value (2)
≤ 3 hours; N=72 (55.4%) 26 (36.1%) 0.006 41.0 ± 21.1 0.039
3-6 hours; N=30 (23.1%) 17 (56.7%) 51.4 ± 20.4
6-12 hours; N=16 (12.3%) 3 (18.7%) 39.1 ± 18.1
≥ 12 hours; N=12 (9.2%) 1 (8.3%) 36.2 ± 21.2
Time delay in Prasugrel/Ticagrelor group (N = 42)
≤ 3 hours; N=24 (57.0%) 2 (8.3%) NS 24.7 ± 20.4 NS
3-6 hours; N=9 (21.5%) 0 14.1 ± 8.2
6-12 hours; N=6 (14.4%) 2 (33.3%) 24.4 ± 24.7
≥ 12 hours; N=3 (7.1%) 0 17.0 ± 19.5
